STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION 
For procedures finalised after 01 December 2001 please refer to module 8B. 
• 
• 
• 
• 
• 
• 
• 
• 
On 8 November 1999, the Marketing Authorisation Holder (MAH) submitted an application for 
a  Type  I  variation  (I/01)  in  accordance  with  Commission  Regulation  (EC)  No.  542/95.  The 
MAH  applied  for  a  minor  change  of  manufacturing  process  of  the  active  substance.  On  16 
December  1999  the  EMEA  approved  the  variation,  which  did  not  lead  to  any  changes  to  the 
Commission Decision. 
In accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992, the EMEA 
issued  on  19  December  1999  a  Notification  for  amendment  of  the  addresses  of  the  local 
representatives mentioned in the Package Leaflet, and some aspects of the Labelling, as applied 
by the MAH.  (N/02)  
On 9 March 2000, the MAH submitted an application for a type I variation (I/03) in accordance 
with Commission Regulation (EC) 542/95 as amended, related to a change in test procedures of 
the medicinal product. On 6 April 2000 the EMEA approved the variation, which did not lead to 
any changes to the Commission Decision. 
On 9 March 2000, the MAH submitted in parallel three applications for type I variations ( I/04, 
05,  &  06  )  in  accordance  with  Commission  Regulation  (EC)  542/95  as  amended,  related  to  a 
change in test procedures of the medicinal product. On 25 May 2000 the EMEA approved the 
variations, which did not lead to any changes to the Commission Decision. 
On 9 March 2000, the MAH submitted an application for a type I variation (I/07) in accordance 
with Commission Regulation (EC) 542/95 as amended, related to the deletion of the alternative 
site for packaging of the finished product. On 6 April 2000 the EMEA approved the variation, 
which did not lead to any changes to the Commission Decision. 
On  22  April  1999  the  MAH  submitted  an  application  for  a  Type  II  variation,  (II/08)  in 
accordance  with  Commission  Regulation  (EC)  No.  542/95,  as  amended.  The  Marketing 
Authorisation  Holder  applied  for  a  modification  of  the  shelf  life  specifications  of  the  finished 
product, namely to widen the shelf life limits for the active ingredient. The CPMP adopted on 
21 September 2000 an Opinion on the Type II variation, which did not lead to any changes to 
the Commission Decision. 
In accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992, the EMEA 
issued on 9 June 2000 a Notification for amendment of the addresses of the local representatives 
mentioned in the Package Leaflet, as applied by the MAH. ( N/09).  
On  26  September  2000,  the  MAH  submitted  in  parallel  two  applications  for  type  I  variations 
(I/10 and I/11) in accordance with Commission Regulation (EC) 542/95 as amended, related to 
the replacement of an excipient with a comparable excipient. On 27 October 2000 the EMEA 
approved these variations which did not lead to any changes to the Commission Decision. 
1/2 
EMEA 2005 
 
 
 
 
 
 
 
 
Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below: 
Scope 
To  update 
the  Summary  of  Product  Characteristics  (SPC), 
sections 4.2 "Posology and Method of Administration", 4.4 "Special 
warnings  and  special  precautions  for  use",  4.6  "Pregnancy  and 
lactation", 4.8 "Undesirable effects" and 5.3 "Preclinical safety data" 
and  related  relevant  sections  of 
the  Package  Leaflet  (PL). 
Furthermore,  the  Marketing  Authorisation  Holder  (MAH)  proposed 
some minor changes in the SPC, Labelling and PL in order to bring 
the text in line with the latest QRD/ EMEA templates. 
Change  in  process  controls  applied  during  the  manufacture  of  the 
product. 
Application 
number 
Type of 
modification1 
Notification/ 
Opinion 
issued on2 
II/0012 
II 
26.07.01 
Commission 
Decision 
Issued/amended 
on 
21.11.01 
I/0013 
I 
14.05.01 
N/A 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers 
to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a 
minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an 
Annex II application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) 
No 2141/96 of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 
March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification 
date. The Commission Decision will be amended accordingly. 
2/2 
EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      
 
